Introduction
Although the place of enzyme-catalyzed reactions in clinical biochemistry has proven to be of diagnostic value since the late 1950s (16, 17) , it is only within the last 6 years that methods for determining the activity of proteases have been introduced into the clinical laboratory. Proteolytic enzymes are assuming increasing significance in biological regulation. An understanding of their physiological and pathological roles has come from both biochemical and histochemical standpoints. Proteases, unlike most hydrolases, the general class of enzymes to which they belong, are highly specific and precisely controlled. Furthermore, when this precise control of proteolysis breaks down, the consequences are usually serious. It has long been recognized by physiological chemists that many disease states represent abnormalities of protein synthesis or degradation resulting from disturbances in the activity of proteases or their inhibitors.
First attempts at assaying for specific proteases by preparing synthetic substrates were made by Fruton and Bergmann in the 1930s. They found that crude preparations from bovine spleen and partly purified preparations of pepsin and trypsin could hydrolyze small synthetic substrate molecules with free amines. The task for assaying protease activity was greatly simplified when in 1950, Neurath and Schwert demonstrated that amino acid esters were very sensitive substrates. Such substrates were used by Sherry and Troll (58) and associates in the mid-1950s to study clotting and fibrinolytic enzymes. It was Gomori, in 1954 , who used chloroacetyl-/3-naphthylamine with ammonia to obtain glycine and D,L-alanyl-/3-naphthyl-'Presented as part of the program at the 1982 Joint Meeting of the American and Japanese Histochemical Societies, held in Vancouver, British Columbia, Canada, July [20] [21] [22] [23] [24] 1982 . 2 Portions of this work was performed under the auspices of the U.S. Department of Energy by the Lawrence Livermore National Laboratory under contract number W-7405-ENG-48; other parts were carried out at Enzyme Systems Products Inc. as designated in the text.
amides as the first chromogenic substrates for aminopeptidases (18) . In 1955 Green et al. (20) and Folk and Burstone (13) synthesized L-leucyl-/3-naphthylamide.
The Early Years: Developing Substrates for Aminopeptidases, Trypsin, and other Proteases
The work of Green and co-workers established the premise of Emil Smith that while specificity of the substrate was provided by the amino acid, the nature of the leaving group linked by an amide bond to the leucyl radical had only a minor influence on specificity; thus leucine aminopeptidase could hydrolyze N-substituted leucylamides. Subsequently, Burstone and Folk demonstrated that L-leucyl-(3-naphthylamide was a highly successful histochemical substrate for aminopeptidase activity. In delving back through the literature, to the best of my findings, Green and co-workers were the first to employ the Bratton-Marshall method with a /3-naphthylamide substrate for identifying a protease in human serum, and to further demonstrate that leucine aminopeptidase was elevated in sera from pregnant women. In 1957 Tuppy and Nesvadba (67) reported several new substrates that were employed in the study of serum aminopeptidases in pregnant women; among the compounds were L-cystine di-/3-naphthylamide and D,imethionine /3-naphthylamide. In 1958 Rosenblatt et al. (53) reported the synthesis of L-leucyl-4-methoxy-/3-naphthylamide; Nachlas et al. (41) subsequently reported (in 1960) on the histochemical application of the modified leucyl substrate, and claimed that the presence of the methoxy group in the 4 position permitted coupling 40 times as fast as 2-naphthylamine. In 1959 Riedel and Wunsch (52) synthesized a new substrate for the measurement of trypsin activity, a-benzoyl-Larg-13-naphthylamide (BANA). Application of this substrate as a histochemical reagent in the study of mast cells was reported by Glenner and Cohen (15) . With this one exception, the histochemical demonstration of proteolytic enzymes remained limited to the demonstration of aminopeptidases, until SMITH Hopsu-Havu and Glenner, in 1966 (24) , localized in rat kidney cortex cells the reaction product for a dipeptidyl aminopeptidase: the substrate glycl-prolyl-,f3-naphthylamide (Gly-Pro-/3-NA).
The First Direct Colorimetric Assays
An objection raised by biochemists in the use of /3-naphthylamine derivatives as substrates for determining enzyme activity was that a second reaction was necessary to generate a colored product, thus limiting the ability to conduct direct kinetic studies. In 1961 Erlanger et al. (12) reported the development of a chromogenic amidolytic assay for trypsin with the liberation of p-nitroanilide (PNA) that could be directly evaluated in the spectrophotometer. Subsequently, Planta and Gruber (49) developed the first direct colorimetric assay for a proteinase in which the substrate contained more than one amino acid. In 1963 they reported that cathepsin C (DAP-I) cleaved the arylamide bond in Gly-Phe-p-nitroanilide.
Shortly thereafter, Nachlas et al. (42) reported their search for more sensitive substrates than BANA for trypsin activity. They made substrates having varying groups attached to the amino group of Arg-f3-naphthylamide that yielded either di-, tri-, or tetra-amide compounds. They were the first to show that the rate of substrate hydrolysis was closely associated with the chain length of amino acids, and that specificity was apparently determined not only by the amino acid attached to the leaving group, but to some degree by the nature of each amino acid. For example, the most active substrate, N"-CBZ-Gly-Gly-Arg-/3-naphthylamide was hydrolyzed by trypsin 220 times as readily as N'-benzoyl-L-Arg-/3-naphthylamide (BANA) (see Table 2 in ref. 42 ).
The Extended Binding Site Theory and New Oligopeptide Design
Today peptide substrates are synthesized according to the principles of the extended binding site theory, which maintains that substrates do not bind randomly to an enzyme but rather at specific sites. The sites where substrate binding and catalysis occur have been called "active sites." They are highly specific regions where a "closeness of fit" between the substrate and enzyme determines specificity. In 1967 Schechter and Berger (55) conducted a series of investigations that were instrumental in establishing that substrate specificity could not be accounted for simply by a general theory or enzyme binding to a particular single amino acid at the site of peptide bond cleavage, but rather that the contact amino acids involved in catalysis could be as many as seven ( Figure 1 ). This would indicate that specificity of a protease toward an oligopeptide or protein substrate is determined by the amino acids adjacent to the peptide bond cleaved, while secondary binding sites serve as a guide or keylock mechanism for fitting the polypeptide chain across the interacting crevice of the enzyme at the active site. Furthermore, it is realized that the amino acid sequence on both sides of the peptide bond to be cleaved is important to the specificity of the enzyme. While a vast number of theoretical combinations can be generated for the seven amino acid sequence of the 21 naturally occurring amino acids, nature has effectively provided limited specificity to control proteolytic enzyme systems by using only a few amino acids in certain combinations to fit into the crevice of the enzyme.
Synthesis of the First Chromogenic Substrate for Thrombin, and an Excellent Substrate for Cathepsin B
Secondary enzyme-substrate interactions become evident only when the simple substrate containing a single preferred amino acid residue is replaced with an oligopeptide having the same kind of peptide bond for which the enzyme is specific. Thus, in designing and synthesizing oligopeptide substrates it is usually desirable to simulate the sequence at the site of hydrolysis in the natural substrate. Therefore, a major breakthrough in the development of synthetic substrates for proteases occurred with the ability to identify the amino acid sequence around the cleavage site of the natural substrates.
Making use of their previous studies on the amino acid sequence around the active site of fibrinogen (one of the three natural substrates of thrombin), Blombaeck's group in Stockholm, in 1972 (66), used the principles of extended site binding to develop the first chromogenic substrate for thrombin: Bz-Phe-Val-Arg-pNA (S-2160) ( Figure 2 ). In that same year, one decade ago, at the Twenty-Third Annual Meeting in Boston (62, 64) , I presented work from our laboratory on the specificity and sensitivity of a new synthetic substrate for cathepsin B: a derivative of 4-methoxy-2-naphthylamine (MNA). When the amino acid sequence of porcine proinsulin was unraveled by Chance (9) , there was immediate interest in the endogenous enzyme or enzymes involved in clipping out the connecting peptide and converting the inactive hormone into active insulin. It was soon demonstrated that trypsin under very controlled conditions could make the necessary clips. The search was then underway to identify the converting enzyme, thought most likely to be a serine protease. Once again applying the principles described above, we designed and synthesized an oligopeptide substrate around Arg-32 in the proinsulin molecules, cleaving the Arg-Glu bond; Glu was replaced by the leaving group and the N terminal of Ala was blocked to make it an endopeptidase substrate. Our biochemical studies established the substrate to be a poor one for trypsin, but with excellent K"/kca, values for papain and cathepsin B. The substrate has subsequently been used in a wide variety of biochemical and histochemical studies to define cathepsin Blike activity in many different physiological and pathological processes.
In the time that has elapsed, many peptide sequences have been made into N-substituted amide substrates capable of measuring amidolytic rather than esterolytic activity of serine, cystine, and acid proteases, often with a choice of several different leaving groups, for either colorimetric or fluorometric determination.
Oligopeptides in Histochemical Studies
Presently in histochemistry, the capability exists with oligopeptide derivatives of 4-methoxy-2-naphthylamine to investigate the activity of over 50 proteases by light, fluorescence, and electron microscopy ( Figure 3 ). Several articles on the subject have appeared in the past year in histochemical journals, e.g., Journal of Histochemistry and Cytochemistry, Journal of Histochemistry, Histochemie, and the Japanese Journal of Histochemistry. Papers at this meeting by Garrett et al. (14) , Gossrau (19) , Sannes (54) , and Yamato et al. (74) represent continued interest in the activity of proteases within cells and tissues. Yet the impact of these histochemically derived techniques on diagnostic medicine have not come through histochemical studies but rather by their application to the quantitation of various proteases in body fluids.
Substrate Kits and Automated Analyzers: Technologies for Measuring the Activity of Clotting Factors
In 1976 Kabi, Ortho Diagnostics and Boehringer Mannheim introduced chromogenic substrate kits, derivatives of p-nitroaniline, into the blood coagulation field. Until that time the only indicator reaction available for the determination of clot- ting factor activities was the conversion of fibrinogen into fibrin. All function tests of the coagulation system-both overall tests and single factor determinations-were based upon measurement of the time required for the fibrinogen-fibrin reaction to produce a clot. The ability to determine the activity of coagulation and fibrinolytic enzymes by photometric methods with specific substrates for each factor was seen as the ultimate technology in the field of hemostaseology. 
Other Protease Tests in Diagnostic Medicine
Presently there are only four protease tests routinely performed in the clinical laboratory: heparin, antithrombin III, plasminogen, and cs 2 -antiplasmin (3). The clinical value of these assays is being demonstrated in hematology and clinical chemistry laboratories every day in hospitals throughout the world (3, 7, 8, 33, (37) (38) (39) 52) . Here in Vancouver, at the Walter Koerner Acute Care Hospital, Dr. Rodger Hill exhibited to me the propinquity of hematology and clinical chemistry and the utilization of the DuPont ACA to conduct blood coagulation tests; these have led to significant improvement in patient care.
Of the contributions histochemistry and synthetic oligopeptide substrate technology have made to diagnositc medicine, the heparin assay probably ranks first (10) . It is extensively used in heparin management by surgical teams performing cardiovascular procedures that require the administration of high levels of heparin followed postsurgically by neutralizing doses of protamine. In minidose heparin therapy for prophy-laxis of postoperative thromboembolism, heparin monitoring is proving unique in ascertaining whether subcutaneously administered heparin is being adequately absorbed. Routine clotting tests are not affected by minidose heparin therapy.
The Growth of Highly Sensitive Detection Methods
The above four assays do not require a high degree of sensitivity; consequently, activity in plasma can be determined colorimetrically (1, 2) or with a moderately intense fluorophore (Figure 4 ). However, some proteases of the hemostatic system (11) and most tissue proteases (4) found in body fluids are present in relatively smaller quantities, even under pathological conditions, and require a much more sensitive detection system to be accurately quantitated (44) .
Fluorescent Leaving Groups
Radioimmunoassay is considered the most sensitive method of analysis. However, with the introduction of 4-methyl-7aminocoumarins as fluorescent leaving groups in the assay of proteases, sensitivity has been demonstrated to be potentially equal to that of enzyme radioimmunoassay in detection limit. The quantum efficiency of 7-amino-4-trifluoromethyl coumarin is 40 times that of 4-methoxy-2-naphthylamine, and 100 times that of 5-aminoisophthalic acid dimethylester (46) (Figure 5 ). Zimmerman et al. (76) introduced 7-amino-4-methyl coumarin (AMC), first in the assay of elastase and subsequently for plasmin, urokinase, and plasminogen activators (48, 77) . The leaving group, attached through the arylamide bond to a multiform of oligopeptides, is now widely used in the assay of a diverse number of proteases.
Current Research in Japan
A great deal of clinical research on proteases has been conducted in Japan, and AMC derivatives are quite popular substrates there. Much interest in Japan, apparent from the recent literature, is on a protease, dipeptidyl aminopeptidase IV. Takeshi Kato, in the Department of Life Chemistry, Tokyo Institute of Technology, has studied the activity of this protease in urine from patients with renal disease (23) and in the serum of patients with gastric carcinoma, using the substrate 7-Gly-Pro-amide-4-methyl coumarin (75) . In the coagulation-fibrinolytic field, Hisao Kato at Kyushu University has evaluated human plasminogen against a number of peptidyl derivatives of AMC with Lys residues at the P, and P, sites (29) .
Applications with a Unique Sensitive Leaving Group: 7-Amino-4-Trifluromethyl Coumarin (AFC)
In 1980 at our laboratory we introduced 7-amino-4-trifluoromethyl coumarin (AFC) as a leaving group (46, 65) . Our intention was to synthesize oligopeptide substrates that, upon catalysis by a specific protease, would release a leaving group with high substantiality that could be used in histochemistry and flow cytometry. AFC fell short of achieving our desires in flow cytometry, but it had remarkable properties, extremely useful in the assay of proteases in body fluids. Whereas acylated derivatives of AMC and AFC have a blue fluorescence, and liberated AMC has a slightly shifted, higher blue fluorescence, liberated AFC fluorescence is shifted into the green region of the spectrum. This increase in spectrum difference (Stokes shift) between the emission peak of peptidyl derivatives of AFC and the emission peak of the free coumarin results in the ability to achieve lower detection limits of protease activity than with the use of AMC chemistry. Using selected oligopeptide derivatives of AFC, and a centrifugal fast analyzer-Multistat III from Instrumentation Laboratories-we have automated fluorescence assays for aminopeptidase B and M, cathepsins B and H, plasminogen, plasma kallikrein, glandular kallikrein, and two inhibitors: antithrombin III and heparin. The composition of a specific substrate with a very sensitive leaving group, such as AFC, in an automated system of analysis with optimal pH and activating conditions, makes it possible to attain detection limits of enzyme activity equal to that of total antigen in a radioimmunoassay (46) .
Using Gel Techniques to Identify Isozymes
The uniqueness of the AFC substrates has afforded us a potential not possible with MNA or AMC substrates: the identification of isozymes of a protease on cellulose membranes subsequent to analytical isoelectric focusing. Just last year, in the November issue of Histochemistry, Lojda and Kulich (31), presented the first evidence for different molecular forms of several peptidases by flatbed analytical isoelectric focusing of crude-tissue homogenates and cell lysate samples, followed by staining strips of slab gels in media containing discriminating substrate and fast blue B salt.
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Detector Group
Spectral Characteristics para-nitroaniline Yellow color when cleaved from peptide (405 (pNA) nm). May also be coupled with p-dimethylamino-cinnamaldehyde to yield a colored NO2 O NH 2 schiffbase compound (570 nm). sented a method for the staining of cathepsin B isozymes in which, following slab gel isoelectric focusing, a piece of Whatman 3 mm chromatography paper is placed onto the gel, saturated with substrate solution, the system incubated, and isozyme bands subsequently color developed. In both laboratories, substrate derivatives of 4-methoxy-2-naphthylamine were utilized.
Regardless of the approach employed with MNA substrates, however, there are inherent limitations in the meth-odology of developing color bands after either gel electrophoresis or isoelectric focusing. Color diffusion and fading are well-recognized limitations, yet they are in reality less difficult to deal with than the problems encountered in band color development, precipitation of the coupling agent because of the requirement to include activators in the media for certain proteases, and the frequent necessity to concentrate the enzyme within a sample for sufficient detection. Consequently, it is virtually impossible to detect the presence of tissue protease isozymes in serum and other body fluids by colorimetric methods. The fluorometric determination of immobilized AFC, liberated from oligopeptide substrates impregnated into cellulose acetate membranes, affords sensitivity in detection and resolution of isozymes for many proteases at sample dilutions found in body fluids. I envision new diagnostic discoveries by embracing this fluorescence technology, as described below.
The Next Steps
In an effort to optimize the fluorometric detection of isozymes of proteolytic enzymes following analytical isoelectric focusing of samples, I have been studying glandular kallikrein and cathepsin B activity in crude homogenates of various animal tissues, human body fluids (i.e., serum, breast fluid, and urine (63) , and purified preparations of the two proteinases. In general terms, the technique is as follows.
Analytical isoelectric focusing was done with Servalyt Precote 100 µ polyacrylamide slab gels (No. 42974, pH 3-6, Ampholine, Serva, Garden City Park, NY) using a Hoefer HE 900 System (Hoefer, San Francisco, CA). Electrophoresis was performed at 5°C using a controlled water circulating unit, and gels were prefocused for 15 min at 100 volts with samples subsequently applied in a volume of 8 µl to a small 2 x 4 mm piece of Whatman 3 mm paper and placed on the surface of the gel. Focusing was then continued by raising the voltage slowly during the first 10 min from 10 to 100 volts and thereafter essentially following the schedule outlined by Serva. On each gel a Serva protein Test-Mixture 9 sample was run and electrophoresis was terminated when the myoglobin was visible as a sharp band at the cathode and when there was no longer a drop in current. Immediately following the completion of focusing, a sheet of cellulose acetate membrane, previously impregnated with buffered substrate along with the incorporation of activating and inhibition agents, was dipped into a bath of distilled water to moisten and carefully layed onto the surface of the gel. These impregnated membranes are stable for 2-4 months as long as they are stored in sealed envelopes in a tight plastic box containing calcium carbonate (technique of substrate impregnation developed by Enzyme Systems Products, Livermore, CA). Gels with the membrane firmly attached were incubated in a humidified box at 37°C for the different lengths of time required to develop polymorphic bands of the protease being studied. The synthetic substrate D-Val-Leu-Arg-AFC, along with soybean trypsin inhibitor and buffered at pH 8.2, was impregnated into membranes and used for the study of glandular kallikrein (see Figure 7) . The stubstrate Bz-Val-Lys-Arg-AFC, along with aprotinin, ethylenediamine tetraacetic acid (EDTA), D,L-dithiothreitor (DTT), and buffered at pH 6.0, was impregnated into membranes and used for the study of cathepsin B (see Figures 8-10 ).
Histochemical Studies
In the history of enzymology, much of the development has come through histochemistry (8) . Contributions from the laboratories of Gomori, Burstone, Seligman, and Glenner were imperative in establishing the fundamentals of proteolytic en-zyme histochemistry. These four men hold a special place of recognition, not only for their individual achievements, but for the way they taught others to approach their objectives through sound biochemically oriented basic practices. After a step progression, synthetic substrates can now be designed and synthesized with protease specificity and sensitivity equal to those of radioimmunoassay determination of antigenic structure. Consequently, revitalization of the entire discipline of isozyme detection (22) seems the next eventful step in the future of histochemistry and subsequent application to clinical enzymology.
Isozymes, and their Role in Cancer
Although the physiological significance of isozymes is not wellunderstood, it is clear that they play an important role in the modulation of gene expression (27) . There are several recognized classical examples of isozymes that can appear during the life cycle, and under experimental and pathological conditions. These include the genotypic expression of the B isozyme variant of (3-hexosaminidase; EC 3.2.1.30, a lysosomal enzyme (64) ; and the Regan isozyme of alkaline phosphatase.
Proteases are the regulators of intracellular protein turnover, one of life's most highly orchestrated processes; therefore, we might assume that identification of isozyme patterns of tissue proteases would lead to a much better understanding of their functions, from precursor processing (77) to cancer. Greenstein (21) considered that the enzyme complements of tumors tended to resemble each other more closely than they do those of normal tissues, and more than complements of normal tissues resemble each other. The comparison of cancerous and embryonic tissues was first made more than a century ago. The knowledge of isozymes has made it possible to study the fetal characteristics of cancer (70) . Knox (30) has stressed the quantitative analogies between the enzymic complement of fetal and neoplastic tissues, and has given convincing evidence of similarities between the enzymatic composition of fetal liver and that of hepatoma. Expression of the oncofetal gene for the isozyme of y-glutamyltranspeptidase as a tumor marker confirms Greenstein's generalization (56, 68, 73) .
There is convincing evidence for the involvement of at least two tissue proteases in neoplasia: plasminogen activator (5, 25, 43, 50, 69) and cathepsin B (51, 60) . Plasminogen activators have been implicated in various aspects of malignant behavior. Evidence concerning the presence of differing tissue activators and the likelihood of oncofetal isozymes is just beginning to be revealed (57, 72) . Several lines of evidence also implicate a cathepsin B-like cysteine proteinase in tumor invasion of healthy surrounding tissues, the formation of metastases, and elevated levels that correlate positively with the metastatic potential of several cell lines (69) . The identification of cathepsin B has been made possible by a highly selective synthetic oligopeptide substrate, Bz-Val-Lys-Lys-Arg-AFC, capable of quantitating the enzyme to the picogram level of activity. When this substrate, impregnated into a cellulose acetate membrane in the presence of D,L-dithiothreitor (Cleland's Reagent; DTT), EDTA, and aprotinin, is applied to the surface pH 6 pH 3 To establish whether there is any significance to these staining patterns many more human breast fluid samples are being studied.
of an ultrathin Serva Precote polyacrylamide slab gel, subsequent to isolelectric focusing, isozymes of cathepsin B can be identified in samples of tissue homogenates and some body fluids. In partly purified preparations of rat liver, 10 bands were identified in a narrow pI range (Figure 8 ). In breast fluid samples from four women with no known mammary gland pathology, and two women with benign tumor or hyperplastic tissue, we found 3 distinct polymorphic bands staining for cathepsin B activity, while in samples from one woman with ductal carcinoma and one with malignant carcinoma we found a very light fluorescent intense fourth band. Furthermore, the 3 bands corresponding to those in controls, from the breast fluid samples of the two women with carcinoma, stain more intensely for enzyme activity, when adjusted to equal protein content before applying the sample to the gel and electrofocusing. The significance of these observations of isozymes in breast fluid samples awaits the investigation of many more samples. A diagnostic potential would be imminent if it could be established that differing isozyme patterns in a physiologic or pathologic state are conformable (32, 35, 47) , and whether alterations in isozymes are due to variations in rates of their synthesis or to activation from inactive preexisting protein. To this latter point, looking into the future, two-dimensional electrophoretic analysis may play an important part in establishing the antigeneity to catalytic relationship of an isozyme by subsequent staining of gels to electrophoresis (28, 36, 60) .
Cathepsin B Isozymes in Mammary Carcinoma
Conclusion
There is no doubt about the impact of histochemistry in the development of the proteolytic enzyme detection system in diagnostic medicine. To be sure, the past is a prologue, and in enzyme histochemistry, discoveries and applications abound, waiting for the prepared mind.
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